BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:4th Annual Pharma Pricing\, Reimbursement &\; Market Access 2021\n\n29th - 30th June 2021\, Virtual Conference (Time Zone - BST)\n\n This conference will provide an overview of global pricing\, market acces s systems and cost management techniques\, as well as in-depth discussion of some of the most current trends and changes. This Conference will bri ng together top pharmaceutical\, biotechnology and regulatory representat ives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences. F ollowing a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU\, it gives me great pleasure in welcoming all of you to the Virtue Insight’s 3rd Annual Pharma Pricing\, Reimbursement &\; Market Access 2020. \; I wish and pray that all our efforts will be beneficial to our industry and to our country at larg e.\n\nDELEGATE REGISTRATION:\n\nEmail: kavitha@virtueinsight.co.in \; or Call: +44-20 3509 3779\n\nPlease note that this is a PAID event and N OT A FREE event (no complimentary passes available). Any invite\, email o r tickets issued mentioning it as a free pass or free ticket to this even t through any third party site will strictly not be accepted by the organ izer. \n\nEARLY BIRD PRICE\n\n1 Delegate @ £300 +VAT (Valid Till 24th May 2021)\n\n3 Delegates @ £700 +VAT (Valid Till 24th May 2021)\n\nSTANDARD PRICE\n\n1 Delegate @ £500 +VAT (Valid From 25th May 2021)\n\n3 Delegates @ £1200 +VAT (Valid From 25th May 2021)\n\nConference Sponsor\, Exhibiti on Stall &\; Paid Speaker Slot - Please email your interest and querie s to kavitha@virtueinsight.co.in\n\nKEY SPEAKERS:\n\n\nGERGANA ZLATEVA\, Vice President and Business Unit Lead\, Oncology\, Patient &\; Health Impact\, Pfizer\nVIVECA PARKER\, Assistant US Attorney\, Dept of Justice\ nADAM LEVYSOHN\, Head of Biogen Value &\; Access Alzheimer’s Disease\, Biogen\nMARIA \;ALEJANDRA BLANC\, Director - Regulatory Affairs\, Ab bvie\nMARIO OUWENS\, Senior Statistical Science Director\, Group director Medical &\; Payer Evidence Statistics\, AstraZeneca\nLAURENE REDDING\ , Head\, Value\, Access &\; Policy\, BeiGene\nLARA PIPPO\, Head of Mar ket Access &\; Government Affairs\, CSL Behring\nSAMUEL MURPHY\, VP &a mp\; Head of International BD\, Shenzhen Salubris Pharmaceuticals\nVIJAY REDDY\, Senior Director - Global Market Access Strategy\, Biocon Biologic s\nALEEN HOSDAGHIAN\, Brand Lead\, US Immunology\, UCB Pharma\nJESPER BJE RGGREN\, European Market Access Lead\, Digital Health\, Teva Pharmaceutic als\nOMAR ALI\, Pharmacist Consultant\, QIPP Adviser Payer Network\nSARAH GARNER\, Acting Program Manager - Access to Medicines and Health Product s\, WHO\nMARCO MARCHETTI\, Director\, National Center for HTA\, Istituto Superiore di Sanità\nMARTIN SCHUCHARDT\, Global Market Access &\; Pric ing Lead\, Almirall\nNURIYA MUSINA\, Head of Development\, Center of Heal thcare Quality Assessment and Control\, Ministry of Health of The RF\nROB ERT POPOVIAN\, CEO\, Former VP\, Gov Relations\, Conquest Advisors\, Pfiz er\nLUC BOILEAU\, President - Director General\, INESSS\nISABELLE GANACHE \, Director\, INESSS\nOLIVER LEATHAM\, VP\, Global Head of Commercial Str ategy and EU Value &\; Access\, Certara\nMARTIJN NEGEN\, VP Commercial Strategy\, AM Pharma\nIGOR RUDYCHEV\, Vice President\, Enterprise Analyt ics\, Horizon Therapeutics\nROSEMARY JOSE\, Senior Director\, Strategic M arket Access\, Open Health\nJUAN VERGEZ\, Head of Marketing &\; Corpor ate Communications\, Arvelle Therapeutics\nERIN MISTRY\, SVP Payer Strate gy\, Government Affairs and Trade\, Cormedix\nREED STEPHENS\, Partner\, W inston &\; Strawn\nTIM EPPLE\, Principal\, Financial Services\, Avaler e Health\nALEXANDER NATZ\, Secretary General\, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)\nMICHAEL THOMPSON\, President &\ ; CEO\, National Alliance of Healthcare Purchaser Coalition\nSANDY EISEN\ , Chief Medical Officer\, Frontline Pharma Consulting Ltd\n\nPlus more jo ining soon\n\nKEY THEMES DISCUSSED IN THIS CONFERENCE: \n\n\nPreparing yo ur best market access strategy\nEU and US policy challenges for market ac cess: Stepping ahead\nUnrivalled opportunity to expose and address the ma rket access challenges facing the industry\nCurrent &\; future - Chall enges &\; opportunities in pharma pricing\, reimbursement &\; marke t access\nImproving patient and market access through the development of targeted value propositions\, comprehensive contract assessment\nMeasurem ent strategies through to in-depth knowledge regarding payer formulary co verage trends\nHow can payers and industry work together to ensure that i nnovative and valuable treatments make it to the market?\nUnderstanding - payers’ perspective\nAdvocating and collaborating with payers for value in a new era\nCreating a robust patient services and reimbursement suppor t program for biosimilar products\nPrioritising Patients! - Adding value through an innovative patient-centered approach\nUnderstand how price aff ects market access and learn on how to set prices for optimal access and returns.\nNew drugs are failing to gain reimbursement from payers/HTAs at an alarming rate\, despite being approved by regulators\nEvidence Genera tion - The strategic rigor and creativity applied to evidence generation\ nImpact of social media and digital analytics\nDeveloping risk-sharing re imbursement models and value based pricing\nPatient engagement and adhere nce within the environment\nExplaining how to use the data sources and ob servational research for effective safety analysis\nDwell ahead of regula tory developments &\; improving your strategies in a cost effective wa y in EU\, US\nAccelerating new medicine introduction in developing world &\; overcoming challenges\nBe part of a major networking opportunity\n \nWHO SHOULD ATTEND: \n\nSenior Vice Presidents\, Vice Presidents\, Senio r Executives\, Global Heads\, Heads\, Directors\, Senior Managers\, Manag ers of:\n\nPricing\, Reimbursement\, Market Access\, Commercial Pricing\, Pricing Strategists\, Health Economics\, Outcomes Research\, Regulatory Affairs\, Governmental Affairs\, Public Affairs\, Public Policy Directors \, Operations\, Governmental bodies\, Regulatory bodies\n\nGet more from the event\, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking t ime\, meet the leading international vendors showcasing the products of t omorrow in the virtual exhibition area. Expand your knowledge of the late st business models and strategies in the high-level conference.\n\n \ ;\n\n \; \; \; \; \; \; \; \; \;  \; \; \; \; \; \; \; \; \; \; \;& nbsp\; \; \; \; \; \; \; \; \; \;&nbs p\; \; \; \; \; \; \; \; \; \; \;  \; \; \; \; \; \; \; \; \; \;&nb sp\; \; \; \; \; \; \; \; \; \; \ ; \; \; \; \; \; \; \; \; \; \;&n bsp\; \; \; \; \; \; \; \; \; \;  \; \; \; \; \; \; \; \; \; \; \;& nbsp\; \; \; \; \; \; \; \; \; \;&nbs p\; \; \; \; \; \; \; \; \; \; \;  \; \;\n DTEND:20210630T170000 DTSTAMP:20260416T150338Z DTSTART:20210629T090000 LOCATION:\, SEQUENCE:0 SUMMARY:4th Annual Pharma Pricing\, Reimbursement &\; Market Access 202 1\n29th - 30th June 2021\, Virtual Conference (Time Zone - BST)\nThis con ference wil... UID:94172794-5cc5-47ff-9e4d-5dee222f41d1 END:VEVENT END:VCALENDAR